Boston Trust Walden Corp Raises Stock Holdings in Mettler-Toledo International, Inc. $MTD

Boston Trust Walden Corp grew its position in Mettler-Toledo International, Inc. (NYSE:MTD) by 1.2% in the 1st quarter, Holdings Channel.com reports. The fund owned 41,696 shares of the medical instruments supplier’s stock after acquiring an additional 482 shares during the quarter. Boston Trust Walden Corp’s holdings in Mettler-Toledo International were worth $52,587,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds have also modified their holdings of the business. Geneos Wealth Management Inc. boosted its stake in shares of Mettler-Toledo International by 83.3% during the first quarter. Geneos Wealth Management Inc. now owns 66 shares of the medical instruments supplier’s stock worth $78,000 after buying an additional 30 shares during the period. Baird Financial Group Inc. increased its position in Mettler-Toledo International by 3.1% in the 2nd quarter. Baird Financial Group Inc. now owns 1,347 shares of the medical instruments supplier’s stock valued at $1,582,000 after acquiring an additional 40 shares during the period. Jump Financial LLC raised its stake in Mettler-Toledo International by 44.6% during the 2nd quarter. Jump Financial LLC now owns 405 shares of the medical instruments supplier’s stock valued at $476,000 after acquiring an additional 125 shares during the last quarter. Cerity Partners LLC raised its stake in Mettler-Toledo International by 10.8% during the 2nd quarter. Cerity Partners LLC now owns 4,035 shares of the medical instruments supplier’s stock valued at $4,740,000 after acquiring an additional 392 shares during the last quarter. Finally, AXA S.A. lifted its position in Mettler-Toledo International by 2.9% during the 2nd quarter. AXA S.A. now owns 4,625 shares of the medical instruments supplier’s stock worth $5,433,000 after acquiring an additional 131 shares during the period. 95.07% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several research analysts have weighed in on the company. Morgan Stanley lowered their target price on Mettler-Toledo International from $1,475.00 to $1,275.00 and set an “equal weight” rating on the stock in a research note on Tuesday, May 12th. Wolfe Research initiated coverage on Mettler-Toledo International in a research note on Tuesday, June 2nd. They set a “peer perform” rating for the company. Barclays decreased their price target on Mettler-Toledo International from $1,550.00 to $1,500.00 and set an “overweight” rating for the company in a report on Tuesday, April 14th. Wall Street Zen lowered shares of Mettler-Toledo International from a “buy” rating to a “hold” rating in a research report on Saturday, May 16th. Finally, Citigroup dropped their price objective on shares of Mettler-Toledo International from $1,700.00 to $1,550.00 and set a “buy” rating on the stock in a research note on Friday, May 8th. Six investment analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company. According to data from MarketBeat, the company presently has an average rating of “Hold” and an average price target of $1,408.55.

Mettler-Toledo International Trading Up 0.6%

MTD stock opened at $1,307.91 on Friday. The company’s 50-day moving average price is $1,175.62 and its 200 day moving average price is $1,289.99. Mettler-Toledo International, Inc. has a 52 week low of $1,023.05 and a 52 week high of $1,525.17. The company has a market cap of $26.43 billion, a P/E ratio of 30.67, a P/E/G ratio of 2.71 and a beta of 1.24.

Mettler-Toledo International (NYSE:MTD) last issued its earnings results on Thursday, May 7th. The medical instruments supplier reported $8.91 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $8.70 by $0.21. Mettler-Toledo International had a net margin of 21.40% and a negative return on equity of 622.80%. The company had revenue of $947.13 million during the quarter, compared to analysts’ expectations of $943.14 million. During the same period last year, the company posted $8.19 earnings per share. The firm’s quarterly revenue was up 7.2% compared to the same quarter last year. Mettler-Toledo International has set its FY 2026 guidance at 46.300-46.950 EPS and its Q2 2026 guidance at 10.700-10.850 EPS. On average, equities research analysts expect that Mettler-Toledo International, Inc. will post 46.6 earnings per share for the current year.

About Mettler-Toledo International

Mettler-Toledo International Inc is a global manufacturer and distributor of precision instruments and services for laboratory, industrial and food retail applications. The company’s product portfolio includes laboratory balances and analytical instruments, industrial weighing systems, process analytics and sensors, metal detection and x-ray inspection equipment, checkweighers, and a range of automated inspection and data-management solutions. Mettler-Toledo also provides software, calibration and lifecycle services intended to support compliance, quality control and operational efficiency across customer facilities.

The company serves a broad set of end markets including pharmaceutical and biotech laboratories, chemical and food processors, logistics and manufacturing operations, and retail environments where accurate weighing and inspection are critical.